Found 13 matching trials
Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD) PHASE2 This study will evaluate the effect of combination therapy with verteporfin...
Show More Location
Novartis Investigative site
Learn More & Join Trial
Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic Myopia PHASE1 To demonstrate the efficacy of ranibizumab in combination with reduced-flue...
Show More Location
Multiple Locations
Learn More & Join Trial
Ranibizumab and the Risk of Arterial Thromboembolic Events PHASE4 The investigators assume that ranibizumab might be dangerous in patients wi...
Show More Location
De Haar Research Foundation
Learn More & Join Trial
Reduced Fluence Photodynamic Therapy (PDT) With Visudyne in Combination With Lucentis for Age-Related Macular Degeneration PHASE4 In this pilot study the researchers will evaluate the safety and efficacy o...
Show More Location
Eagle Mountain Vision
Learn More & Join Trial
Triple Treatment for Detachment of Retinal Pigment Epithelium Secondary to Polypoidal Choroidal Vasculopathy PHASE4 Study the effectiveness of the treatment detachment of retinal pigment epit...
Show More Location
Universidade Federal de São Paulo - Escola Paulista de Medicina
Learn More & Join Trial
Ranibizumab Versus PDT for Presumed Ocular Histoplasmosis PHASE2 The purpose of this study is to evaluate the change in visual activity of r...
Show More Location
Macula-Retina-Vitreous Service, Midwest Eye Institute
Learn More & Join Trial
Efficacy and Safety of Verteporfin Added to Ranibizumab in the Treatment of Symptomatic Macular Polypoidal Choroidal Vasculopathy PHASE4 This study aims to compare the efficacy of ranibizumab and verteporfin PDT ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular Degeneration PHASE2 The purpose of this study is to compare triple therapy using Photodynamic t...
Show More Location
Bay Area Retina Associates
Learn More & Join Trial
Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization PHASE3 This study evaluated the effect of combination therapy with verteporfin pho...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Safety Study of 2.0mg Lucentis to Treat Polypoidal Choroidal Vasculopathy PHASE1 This Phase I/II study will investigate the safety and tolerability of intra...
Show More Location
Southeast Retina Center
Learn More & Join Trial